Webinar | August 14, 2023

Safety Pharmacology: Best Practices Under ICH E14/S7B For Non-Clinical And Clinical Strategies

Source: Charles River
Laboratory scientists-GettyImages-547131814

The ICH E14/S7B Q&As were released in 2022 which outlined best practices to follow to both align and strengthen the conduct of these studies for consideration in the non-clinical risk assessment, thus providing consistency and confidence in the data for regulators.

Learn how to successfully adopt the ICH E14/S7B guidance revisions and improve your drug development strategy from our experts in safety pharmacology. Scientific experts discuss how the ICH E14/S7B (Q&As) in vitro hERG and in vivo QT assays will be conducted, interpreted, and reported.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Charles River